Innova Vascular
Irvine, US · Delaware corporation · 1 known investors
Innova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Founders & leadership
SS
Sanjay ShrivastavainFounder & CEO
Board
MH
Mike HennessyBoard director
OO
Owen O'NeillBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.9M disclosed across 4 rounds · 2021–2025
▶$5.7MraisedJul 2025 · 10 investors · Other TechnologyRule 506(b)
▶$5.7MraisedJul 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Owen O'NeillDirector
- Sanjay ShrivastavaExecutive Officer, Director
- Mike HennessyDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJul 2025 · 5 investors · Other TechnologyRule 506(b)
▶$10MraisedJul 2025 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sanjay ShrivastavaExecutive Officer, Director
- Owen O'NeillDirector
- Mike HennessyDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJul 2025 · 1 investors · Other TechnologyRule 506(b)
▶$4MraisedJul 2025 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sanjay ShrivastavaExecutive Officer, Director
- Mike HennessyDirector
- Owen O'NeillDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJul 2025 · 2 investors · Other TechnologyRule 506(b)
▶$2.2MraisedJul 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mike HennessyDirector
- Owen O'NeillDirector
- Sanjay ShrivastavaExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapBoston Scientific31 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular29 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
Rf Surgical29 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
NeuroVasc26 shared keywordsNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Bioworld25 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Imperative Care Inc24 shared keywordsImperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey. The company focuses on devices and solutions for patients suffering from devastating vascular conditions.
Companies competing with Innova Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Innova Vascular do?
- Innova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
- Who founded Innova Vascular?
- Innova Vascular was founded by Sanjay Shrivastava.
- Who are Innova Vascular's investors?
- Innova Vascular's investors include Black Diamond Ventures.
- How much funding has Innova Vascular raised?
- Innova Vascular has disclosed $21.9M raised across 4 rounds.
- Where is Innova Vascular headquartered?
- Innova Vascular is headquartered in Irvine, US.